Multiple studies published in the last two years indicate that eggs from chickens immunized againstSARS-CoV-2could be used to create effective treatments againstCOVID-19in humans. There is no evidence, however, that this development is responsible for the current egg shortage in the United States, as some conspiracy theories allege.
In a study published in the Journal of Applied Microbiology March 2022, researchers found that egg antibodies (IgYs) produced by chickens immunized against the SARS-CoV-2 spike protein had the ability to neutralize the virus, specifically by interfering with the spike protein’s capacity to attach to human cells.
The researchers concluded that IgY targeting the spike protein “could be a promising candidate for pre- and post-exposure prophylaxis or treatment of COVID-19.”
They added that “administration of IgY-based oral preparation, oral or nasal spray may have profound implications for blocking SARS-CoV-2.”
A 2021 study published in the journal International Immunopharmacology concluded that anti-spike protein IgYs “showed significant neutralizing potency against SARS-CoV-2 pseudovirus, various spike protein mutants, and even SARS-CoV in vitro.”
The authors concluded such antibodies “might be a feasible tool for the prevention and control of ongoing COVID-19.”
This study also suggested that such a treatment might have several advantages over monoclonal antibodies, including reduced side effects and reduced production costs. As the authors point out, IgYs have been noted by researchers since 1959 for “their stable chemical properties” and low cost, high yield results that make them a potentially more attractive treatment option for developing countries.
When it comes to reduced side effects, the study notes, “IgYs neither bind the human rheumatoid factors, nor activate the human complement system, which minimizes the risks of inflammation.” In essence, egg antibodies do not cause allergy or set off immune reactions when injected into humans.
The study points out that IgY antibodies have also been applied to combat human viral infections such as the respiratory syncytial virus (RSV), influenza virus, and Coxsackie virus.
The authors cite a 2006 study of an earlier SARS coronavirus in which anti-SARS coronavirus IgYs were purified from chickens immunized with an inactive form of the virus, and the resulting antibodies were able to neutralize the live virus both in vitro and in vivo.
A third study published last in Viruses last July by researchers at UC-Davis also found evidence supporting the approach of producing COVID-19 antibodies in birds.
Rodrigo Gallardo, a UC-Davis professor in poultry medicine at the UC Davis School of Veterinary Medicine lauded the approach in an article on the university’s website.
“The beauty of the system is that you can produce a lot of antibodies in birds. In addition to a low cost to produce these antibodies in hens, they can be updated very fast by using updated antigens to hyperimmunize hens, allowing protection against current variant strains.”
The Egg Shortage Theory
The egg antibody research offers such a compelling avenue for COVID-19 treatment that it has spurred questions of a potential conspiracy given the current egg shortage in the United States.
An article in the DCPatriot asked, “Is that why eggs are disappearing at an alarming rate? Is that why chicken farms are being destroyed? We don’t know, but it sure is a ‘what the hell is happening here’ moment, isn’t it?”
However, even though chickens can be used to produce antibodies, they first have to be exposed to the virus. All the studies involved hens that were exposed to the coronavirus. The study published in Applied Microbiology found that a control group of non-immunized IgYs had “no obvious inhibitory effect on the virus” as indicated in the graph below that compares the results of IgYs from immunized hens (blue line) to those of the control group (red line):
Luminescence inhibition rate curve of the anti-(SARS-Cov-2) IgY (blue) and normal (control) IgY (red) from the pseudovirus neutralization assay. (Elsevier COVID-19 resource centre)
There appears to be no scientific evidence then that the eggs in your local supermarket are an effective treatment for COVID-19. Furthermore, the contemplated delivery systems, such as nasal sprays, would deliver a highly refined and concentrated dosage, further enhancing the impact of the antibodies.
Eggs as COVID-19 Fighters
That said, as reported by the Times of India, “coronavirus quarantine facilities around the world, are offering eggs to their patients in recovery with their daily meals.”
The Times reported that authorities are also providing a lot of healthcare workers eggs daily to boost their immunity.
Eggs come packed with amino acids and antioxidants, which improve your health and keep your immune system functioning optimally.
Each egg (85 calories) contains 7 grams of muscle-building protein apart from essential core vitamins like selenium (22 percent) and vitamin A, B and K. Eggs also contain another nutrient, riboflavin, which supports development and growth.
Each egg also provides 27 percent of the RDA of vitamin D, which a recent meta-analysis (2022) of multiple studies has shown to be effective in reducing instances of COVID-19 infection as well as the severity of infections.
Chinese study made coronavirus antibodies in eggs by vaccinating hens
A 2021 study in China investigated antibodies generated by immunizing hens with a specific protein from the SARS-CoV-2 virus and found that the antibodies extracted from yolks could neutralize some versions of the coronavirus tested in the lab.
The results do not mean that all egg yolks contain coronavirus-neutralizing antibodies or that eating eggs would prevent COVID-19, as suggested in some widely shared posts online.
“So EGGS prevent COVID. Do you see it yet?,” reads one Feb. 2 comment on Twitter attaching an extract of the paper that has garnered over 3,600 retweets (here). Other examples can be seen on Instagram (here) (here).
Posts refer to a study originally published in November 2020 (here), which analyzed immunoglobulin Y (or lgY) antibodies generated in the yolks of eggs from laying hens that had been immunized with the “spike” protein from SARS-CoV-2. The researchers then tested the antibodies in human cells in the lab and found that they could block versions of a mock SARS-CoV-2 virus, and even SARS-CoV-1, from binding to the ACE-2 receptor these viruses normally use to enter human cells.
Qinglin Meng, a senior author of the study, did not immediately respond to a Reuters request for comment.
Not all eggs, however, contain the specific antibodies that neutralize SARS-CoV-2, Rodrigo Gallardo, professor in poultry medicine at the UC Davis School of Veterinary Medicine, told Reuters via email.
“Even though all hens and egg yolks contain lgY’s, in order to obtain those that neutralize SARS-CoV-2 you need to immunize (vaccinate) hens with a vaccine containing the virus, proteins, subunits or mRNA from the virus,” he said.
Gallardo coauthored a similar study conducted in 2022 at UC Davis (here) , which found that the purified antibodies from eggs harvested from hens given high doses of the SARS-CoV-2 spike protein could “neutralize” the virus in-vitro (here )
Producing lgY antibodies in eggs by immunizing hens has long been used as a way to generate large quantities of antibody quickly for use in treating diseases in other animals, as described in a 2011 review of the field (here).
During the pandemic, many researchers have also focused on the potential for employing this relatively inexpensive method to produce lgY antibodies in eggs for use in treating or preventing COVID in humans (jogh.org/2022/jogh-12-05009), (here) .
Such treatments are not likely to be delivered by having people consume the eggs. Rather, the process would extract and purify the antibodies made in the eggs, then use them like other antibody medications, which are typically given intravenously (www.mdpi.com/1999-4923/10/3/83) , (www.mdpi.com/1999-4923/10/3/83) .
Some posts referring to the November 2020 Chinese study (whose final version was formally published in January 2021) conflate the false idea that eggs treat COVID with the rise of egg prices in the United States (here) and even with a large fire that broke out at an egg farm in Connecticut on Jan. 28 (here).
One Twitter user commented, “Yes, that may be why there’s a shortage… very fishi,” and another wrote, “That makes a lot of sense now why egg farms are going up in spoke...(sic).”
According to the U.S. Department of Agriculture, however, a worldwide outbreak of avian flu that has killed millions of commercial chickens is among the causes for the increase in egg prices (here)
Hillandale Farms, operator of the egg farm in Bozrah, Connecticut that is mentioned in some posts, has said the cause of the fire is still being investigated (here). The fire would not impact egg prices, a spokesperson for the Department of Agriculture told NBC Connecticut (here).
VERDICT
Misleading. A study in China immunized hens to generate antibodies against SARS-CoV-2 in their eggs, it did not find that all eggs contain such antibodies or that eggs have any effect on COVID.
With only one of the biopharma industry’s top 20 revenue companies seeing a year-over-year decline in sales, 2024 was a remarkable year of revenue growth for the industry. Compare that to 2023, when eight of the top 20 drugmakers experienced revenue declines. Six of the top 20 drugmakers had double-digit increases in 2024, compared to just two in 2023. Five others saw a revenue bump of between 7% and 9%, compared to two reaching those figures in 2023. For the second year in a row, Eli Lilly (32%) and Novo Nordisk (26%) posted Big Pharma's largest year-over-year sales bumps, though their positions were flipped from 2023 when Novo (31%) topped Lilly (20%). Expect the same form in 2025 as Lilly—boosted by sales of its diabetes and obesity drugs Moujaro and Zepbound— projects its sales to fall between $58 billion and $61 billion. At the midpoint of the projection, it would be a 32% increase, matching the sales boom it saw last year. Meanwhile, Novo—which also has been powered by sale...
It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as 2023 featured major patent expirations, the rise of weight loss drugs and other new dynamics, the year’s ranking of the top 10 drugs by global sales featured its fair share of surprises. Merck’s oncology king Keytruda rose to the top last year, adding yet another feather in its cap. With more than 30 indications across various cancer types and stages, the PD-L1 inhibitor shows no signs of stopping. With $25 billion in global sales, the drug accounted for about 40% of Merck’s total revenue last year. Keytruda's sales are expected to reach $30 billion this year. Keytruda had previously fallen right behind AbbVie's Humira, which held the title of the world’s bestselling drug for nine years in a row until Pfizer and BioNTech’s Comirnaty knocked AbbVie’s Humira off its perch in 2021. N...
If you're looking for the best cryptocurrency exchanges in Malaysia in 2025, it's important to choose platforms that are secure and fully compliant with local regulations. In Malaysia, Digital Asset Exchanges (DAX) are regulated and licensed by the Securities Commission Malaysia (SC), which ensures they meet strict standards for investor protection and legal compliance. Luno, Binance, Sinegy, Tokenize Exchange, MX Global, Hata and Torum are popular choices. The best cryptocurrency exchanges work similarly to the best stock trading apps, offering competitive fees and resources on digital marketplaces like mobile or desktop. Crypto enthusiasts can easily buy, sell, and store popular digital currencies like Bitcoin or altcoins like Ethereum. Note that if you don't want to use your exchange's built-in wallet (if applicable), you'll need to set up an external crypto wallet, to store your assets securely. Here are details of cryptocurrency exchanges you can use to buy Bit...
Merck, Roche and Celgene (now part of Bristol-Myers Squibb) have remained prominent players, but the market dynamics have shifted significantly in recent years. This increased competition is fueled by the success of blockbuster drugs like Keytruda (Merck), Tagrisso (AstraZeneca), and Ibrance (Pfizer), as well as the rapid adoption of immunotherapies and targeted treatments ( Verified Market Reports ). Look at 2017. The trio of drugmakers together held a 45.8% share of the market, with longtime cancer leader Roche controlling 26.4% all on its own. In 2024, though, market intelligence firm EvaluatePharma expects to see much more parity. The top three’s share will shrink to 26.2%, with Roche’s dropping all the way down to 11.9%. And the No. 2 through No. 5 companies—BMS, Johnson & Johnson, Pfizer, AstraZeneca and Merck—will boast shares within less than a percentage point of one another. And it won’t just be the heavy hitters clawing for a piece of the pie. That number is set to near...
In 2024, the pharmaceutical industry witnessed significant shifts in research and development (R&D) investments, with companies like Merck & Co. and AstraZeneca making notable strategic decisions that impacted their positions among top R&D spenders. The average cost for major pharmaceutical companies to develop a drug in 2024 rose to $2.23 billion, up from $2.12 billion the previous year. This increase reflects the growing complexity and expense associated with bringing new therapies to market. ( Fierce Biotech ) These developments illustrate the dynamic nature of R&D investments in the pharmaceutical sector, influenced by strategic partnerships, acquisitions, and the escalating costs of drug development. 1. Merck & Co. R&D SPENDING 2024: $17.9 billion Change from 2023: -41% Total 2024 revenue: $64.2 billion R&D budget as percentage of revenue: 28% Market capitalisation: 198.3 B USD (as of June 2025) Merck & Co.’s R&D spending plummeted from the d...
On October 5, 2011, Steve Jobs died after a battle with a rare pancreatic cancer at age 56. But he may have lived longer if he sought proper medical care in time. When Apple co-founder Steve Jobs was first diagnosed with pancreatic cancer in 2003, his doctors advised him to seek surgery as soon as possible. Instead, he delayed the procedure for nine months and attempted to treat himself with alternative medicine. This fateful decision may have quickened Steve Jobs’ death — when he still could’ve been saved. Steve Jobs died from pancreatic cancer complications on October 5, 2011, just eight years after his initial diagnosis. He was only 56 years old when he died, but his cancer had taken such a toll on his body that he looked gaunt, frail, and much older than his actual age. It was a far cry from the robust, energetic man who had once pioneered the personal computer era. ...
Along with gold, silver is in high demand as precious metals are highly sought after as safe havens in uncertain economic environments, boosting prices and assets for top silver ETFs like the iShares Silver Trust (SLV). Investors use silver ETFs for various purposes. Other than its safe-haven benefits, some invest for speculative reasons, hoping to profit from potential increases in silver prices or as a hedge against geopolitical turmoil or currency devaluation. Keep reading to learn more about investing in silver and see a list of top ETFs investing in the precious metal. What Are Silver ETFs? Silver ETFs are exchange-traded funds that provide exposure to the price of silver, a precious metal. These ETFs are designed to track the performance of silver prices, making it easier for investors to gain exposure to the silver market without physically owning and storing the metal itself. Silver's unique combination of properties, including its electrical conductivity, thermal c...
Incidents triggered by lithium-ion batteries are now, on average, a weekly occurrence on U.S. flights, according to the U.S. Federal Aviation Administration (FAA), with cabin crews expressing concern over the risk. This year, 69 lithium battery incidents involving smoke, fire, or extreme heat have occurred on U.S. flights as of Dec. 16, FAA data show. This equates to more than 1.3 incidents per week. Since 2015, the number of such events has increased by more than 330 percent. Between March 3, 2006, and Nov. 5, 2024, a total of 579 lithium battery incidents were recorded, with the majority of cases coming from passenger carriers. Battery packs and batteries accounted for the bulk of these incidents, with 229 events, followed by e-cigarettes/vape devices with 122, cell phones with 81, laptops with 70, and the rest involving other electronic and medical devices. On Nov. 5, a smoke detector alarm from the lavatory of a United Airlines flight coming from San Francisco went off. “Flight a...
Several banks in Malaysia offer business loans tailored for SMEs. Maybank and CIMB are popular choices, offering a variety of loan amounts and competitive interest rates. Other notable options include Public Bank and RHB, while SME Bank and MIDF also provide dedicated financing solutions for small and medium-sized enterprises. SME or also known as Small and Medium-sized Enterprises are businesses that maintain revenues, assets, or a number of employees below a certain threshold. These business entities are often regarded as the heartbeat of Malaysia’s emerging and developing economies. Apart from providing vast numbers of employment opportunities, SME businesses are generally entrepreneurial in nature, helping to shape innovation. Generally, there are two criteria to be met in order for your business to qualify as an SME -- your annual sales turnover and the number of full time employees in your company. This also implies differently for each economy sector: Manufacturing (S...
What's the difference between glutathione and NAD? We will cover the essentials and explain about each of these nutrients below. What is Glutathione? Glutathione or GSH (tripeptide of glutamic acid, cysteine, and glycine) is referred to as the body’s “master antioxidant” or the “mother of all antioxidants” because it is your body’s primary and most prevalent protector, found in all mammalian tissue. Types of Glutathione There is a lot of confusion about GSH and what makes an effective glutathione supplement. There are different types, different formulas, and a lot of different companies saying different things. L-Glutathione or Reduced Glutathione because it is the most commonly found, least expensive, and the true core behind other forms you will find. There is some debate whether L-Glutathione alone can be effective taken orally. The theory being the enzymes in your stomach break it down before it can ever reach the blood stream and become useful. Some evidence ...
Comments